Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinfo Zhitong Wan (金佛止痛丸) is an approved traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Guangzhou Baiyun Mountain Zhongyi Pharmaceutical Co., Ltd. (formerly Guangzhou Zhongyi Pharmaceutical Co., Ltd.). This oral medication is indicated for the treatment of various pain conditions, including stomachache, dysmenorrhea (menstrual pain), peptic ulcer, and chronic gastritis. According to TCM principles, the formulation functions by promoting the circulation of vital energy (Qi), relieving pain, soothing the liver, and regulating the stomach. It is a multi-herb formulation administered orally, typically at a dosage of 5-10 grams, 2-3 times per day during pain episodes. It is contraindicated in pregnant women and those with menorrhagia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jinfo Zhitong Wan.